Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Dickneite

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
International Journal of Immunopharmacology|January 1, 1991
Effect of the new immunostimulator HAB 439 on cell-mediated immunity against intracellular bacteriaG Dickneite, W Schwab, H U Schorlemmer, et al.
Peptide Research|March 1, 1995
Preparation and evaluation of PEG-bound thrombin inhibitors based on 4-amidinophenylalanineW Stüber, R Koschinsky, M Reers, et al.
Pharmaceutical Research|March 1, 1995
Transepithelial transport properties of peptidomimetic thrombin inhibitors in monolayers of a human intestinal cell line (Caco-2) and their correlation to in vivo dataE Walter, T Kissel, M Reers, et al.
Journal of Enzyme Inhibition|January 1, 1995
Synthesis and characterisation of novel thrombin inhibitors based on 4-amidinophenylalanineM Reers, R Koschinsky, G Dickneite, et al.
Behring Institute Mitteilungen|June 1, 1986
The influence of (+/-)-15-deoxyspergualin on experimental transplantation and its immunopharmacological mode of actionG Dickneite, H U Schorlemmer, P Walter, et al.
International Journal of Immunopharmacology|January 1, 1984
The influence of Aclacinomycin A on the immune response and on experimental immune disordersG Dickneite, R Kurrle, F R Seiler, et al.
Behring Institute Mitteilungen|May 1, 1984
Studies on the mechanisms of action of the immunomodulator Bestatin in various screening test systemsH U Schorlemmer, K Bosslet, G Dickneite, et al.
Arzneimittel-Forschung|October 1, 1989
Immunomodulation by the new synthetic thiazole derivative tiprotimod. 3rd communication: influence on host resistance to microorganisms, tumors and on experimental immune disordersH U Schorlemmer, G Dickneite, H Hänel, et al.
Gut|April 1, 1997
Combined treatment with C1 esterase inhibitor and antithrombin III improves survival in severe acute experimental pancreatitisH Yamaguchi, H Weidenbach, H Lührs, et al.
Journal of Thrombosis and Haemostasis : JTH|October 9, 2015
Four-factor prothrombin complex concentrate reverses apixaban-associated bleeding in a rabbit model of acute hemorrhageE Herzog, F Kaspereit, W Krege, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
International Journal of Immunopharmacology|January 1, 1991
Effect of the new immunostimulator HAB 439 on cell-mediated immunity against intracellular bacteriaG Dickneite, W Schwab, H U Schorlemmer, et al.
Peptide Research|March 1, 1995
Preparation and evaluation of PEG-bound thrombin inhibitors based on 4-amidinophenylalanineW Stüber, R Koschinsky, M Reers, et al.
Pharmaceutical Research|March 1, 1995
Transepithelial transport properties of peptidomimetic thrombin inhibitors in monolayers of a human intestinal cell line (Caco-2) and their correlation to in vivo dataE Walter, T Kissel, M Reers, et al.
Journal of Enzyme Inhibition|January 1, 1995
Synthesis and characterisation of novel thrombin inhibitors based on 4-amidinophenylalanineM Reers, R Koschinsky, G Dickneite, et al.
Behring Institute Mitteilungen|June 1, 1986
The influence of (+/-)-15-deoxyspergualin on experimental transplantation and its immunopharmacological mode of actionG Dickneite, H U Schorlemmer, P Walter, et al.
International Journal of Immunopharmacology|January 1, 1984
The influence of Aclacinomycin A on the immune response and on experimental immune disordersG Dickneite, R Kurrle, F R Seiler, et al.
Behring Institute Mitteilungen|May 1, 1984
Studies on the mechanisms of action of the immunomodulator Bestatin in various screening test systemsH U Schorlemmer, K Bosslet, G Dickneite, et al.
Arzneimittel-Forschung|October 1, 1989
Immunomodulation by the new synthetic thiazole derivative tiprotimod. 3rd communication: influence on host resistance to microorganisms, tumors and on experimental immune disordersH U Schorlemmer, G Dickneite, H Hänel, et al.
Gut|April 1, 1997
Combined treatment with C1 esterase inhibitor and antithrombin III improves survival in severe acute experimental pancreatitisH Yamaguchi, H Weidenbach, H Lührs, et al.
Journal of Thrombosis and Haemostasis : JTH|October 9, 2015
Four-factor prothrombin complex concentrate reverses apixaban-associated bleeding in a rabbit model of acute hemorrhageE Herzog, F Kaspereit, W Krege, et al.
Pageof 5